Goodman HM - Search Results

1

The role of cytoreductive surgery in the management of stage IV epithelial ovarian carcinoma.

Goodman HM, Harlow BL, Sheets EE, Muto MG, Brooks S, Steller M, Knapp RC, Berkowitz RS. Goodman HM, et al. Gynecol Oncol. 1992 Sep;46(3):367-71. doi: 10.1016/0090-8258(92)90234-a. Gynecol Oncol. 1992. PMID: 1526516

2

Adenocarcinoma of the uterine cervix: prognostic factors and patterns of recurrence.

Goodman HM, Buttlar CA, Niloff JM, Welch WR, Marck A, Feuer EJ, Lahman EA, Jenison EL, Knapp RC. Goodman HM, et al. Gynecol Oncol. 1989 May;33(2):241-7. doi: 10.1016/0090-8258(89)90560-x. Gynecol Oncol. 1989. PMID: 2649424 Review.

3

Adenocarcinoma of the cervical stump.

Goodman HM, Niloff JM, Buttlar CA, Welch WR, Marck A, Feuer EJ, Lahman EA, Jenison E, Knapp RC. Goodman HM, et al. Gynecol Oncol. 1989 Nov;35(2):188-92. doi: 10.1016/0090-8258(89)90041-3. Gynecol Oncol. 1989. PMID: 2807009

4

Molecular genetic evidence of a unifocal origin for human serous ovarian carcinomas.

Tsao SW, Mok CH, Knapp RC, Oike K, Muto MG, Welch WR, Goodman HM, Sheets EE, Berkowitz RS, Lau CC. Tsao SW, et al. Among authors: goodman hm. Gynecol Oncol. 1993 Jan;48(1):5-10. doi: 10.1006/gyno.1993.1002. Gynecol Oncol. 1993. PMID: 8423021

5

Phase I pharmacokinetic study of the hypoxic cell sensitizer etanidazole with carboplatin and cyclophosphamide in the treatment of advanced ovarian cancer.

Shulman LN, Buswell L, Goodman H, Muto M, Berkowitz R, Teicher B, Kusumoto T, Hurwitz SJ, Kalish LA, Coleman CN. Shulman LN, et al. Int J Radiat Oncol Biol Phys. 1994 Jun 15;29(3):545-8. doi: 10.1016/0360-3016(94)90453-7. Int J Radiat Oncol Biol Phys. 1994. PMID: 8005814 Clinical Trial.

6

Analysis of HPV-positive and -negative vulvar carcinomas for alterations in c-myc, Ha-, Ki-, and N-ras genes.

Tate JE, Mutter GL, Prasad CJ, Berkowitz R, Goodman H, Crum CP. Tate JE, et al. Gynecol Oncol. 1994 Apr;53(1):78-83. doi: 10.1006/gyno.1994.1091. Gynecol Oncol. 1994. PMID: 8175026

7

Involvement of p53 gene in the allelic deletion of chromosome 17p in human ovarian tumors.

Tsao SW, Mok CH, Oike K, Muto M, Goodman HM, Sheets EE, Berkowitz RS, Knapp RC, Lau CC. Tsao SW, et al. Among authors: goodman hm. Anticancer Res. 1991 Nov-Dec;11(6):1975-82. Anticancer Res. 1991. PMID: 1776830

8

Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum.

Muto MG, Welch WR, Mok SC, Bandera CA, Fishbaugh PM, Tsao SW, Lau CC, Goodman HM, Knapp RC, Berkowitz RS. Muto MG, et al. Among authors: goodman hm. Cancer Res. 1995 Feb 1;55(3):490-2. Cancer Res. 1995. PMID: 7834614

9

Use of a second-generation CA125 assay in gynecologic patients.

Hornstein MD, Goodman HM, Thomas PP, Knapp RC, Harlow BL. Hornstein MD, et al. Among authors: goodman hm. Gynecol Obstet Invest. 1996;42(3):196-200. doi: 10.1159/000291954. Gynecol Obstet Invest. 1996. PMID: 8938474

10

Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapy.

Tepler I, Cannistra SA, Frei E 3rd, Gonin R, Anderson KC, Demetri G, Niloff J, Goodman H, Muntz H, Muto M, et al. Tepler I, et al. J Clin Oncol. 1993 Aug;11(8):1583-91. doi: 10.1200/JCO.1993.11.8.1583. J Clin Oncol. 1993. PMID: 8101563

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

347 results

Search Page

Filters